Group 1 - The company, Shanghai Haohai Biological Technology Co., Ltd., will participate in the 2025 semi-annual performance briefing for the biopharmaceutical and CXO industry organized by the Shanghai Stock Exchange to enhance communication with investors [1][2] - The performance briefing is scheduled for September 15, 2025, from 15:00 to 17:00, and will be conducted via video live streaming and online interaction [1][2] - Investors are encouraged to submit questions from September 8 to September 12, 2025, through the Shanghai Stock Exchange Roadshow Center website or via the company's email [2] Group 2 - Key participants in the briefing will include the company's chairman, general manager, financial officer, independent directors, and the board secretary, although adjustments may occur due to special circumstances [2] - After the briefing, investors can access the main content and details of the event through the Shanghai Stock Exchange Roadshow Center [2]

Core Viewpoint - The company, Shuangliang Energy Systems Co., Ltd., is holding a half-year performance briefing on September 15, 2025, to discuss its operational results and financial status for the first half of 2025, allowing for interactive communication with investors [1][2]. Group 1: Meeting Details - The meeting is scheduled for September 15, 2025, from 09:30 to 10:30 [2]. - It will take place at the Shanghai Stock Exchange Roadshow Center and will be conducted via video recording and online interaction [2]. - Investors can participate by logging into the Shanghai Stock Exchange Roadshow Center during the meeting time [2]. Group 2: Participation Information - Investors can submit questions from September 8 to September 12, 2025, through the Roadshow Center's website or via the company's email [1][2]. - The company will address common investor concerns during the briefing, within the limits of information disclosure [1]. Group 3: Key Personnel - Key participants in the meeting include the Chairman, General Manager, Board Secretary, Financial Officer, and Independent Directors [2].

Group 1 - The actual controller of the company, Wen Jianhuai, and Pan Xiaozhen, hold a total of 94,464,489 shares, accounting for 61.24% of the total share capital [1] - After the pledge renewal, the total number of pledged shares by the actual controller is 40,884,282, which represents 43.28% of their total holdings and 26.50% of the company's total share capital [1] - The pledge renewal was completed on September 4, 2024, with new maturity dates set for September 4 and September 5, 2026, without changing the number of pledged shares [1] Group 2 - The controlling shareholder, Xiamen Jianpan Group Co., Ltd., has pledged 65,653,302 shares, which is 42.56% of its holdings, with 27,399,282 shares pledged before the renewal [2] - The actual controller's pledge does not involve new financing arrangements, and their credit status is good, indicating an ability to repay [2] - The overall pledge risk is controllable and will not impact the company's production and operations [2]

Group 1 - The company will participate in the 2025 semi-annual performance briefing for the innovative drug industry on September 16, 2025, from 15:00 to 17:00 [2][3] - The briefing will be held in an online interactive format at the Shanghai Stock Exchange Roadshow Center [2][3] - Key personnel attending the briefing include Chairman and General Manager Zhengyu Yuan, CFO Li Zhile, Independent Director Zhang Huaiying, and Secretary of the Board Nie Anna [2] Group 2 - Investors can participate in the briefing by logging into the Shanghai Stock Exchange Roadshow Center on the scheduled date [2][3] - Investors are encouraged to submit questions from September 9 to September 15, 2025, through the designated online platform or via the company's email [3] - After the briefing, investors can view the main content and outcomes of the event on the Shanghai Stock Exchange Roadshow Center [3]

Core Points - The company is set to elect Zhang Bin as the employee representative director for the eighth board of directors during the upcoming employee representative conference on September 5, 2025 [1][2] - The election aligns with the expiration of the seventh board's term and complies with the Company Law and the company's articles of association [1] - The newly elected board will consist of Zhang Bin and eight directors elected at the third extraordinary shareholders' meeting on September 15, 2025, with the term matching that of the eighth board [1] Summary by Sections - **Election Details** - The election of the employee representative director is scheduled for September 5, 2025 [1] - Zhang Bin has been nominated and meets the qualifications as per legal and regulatory requirements [1] - **Board Composition** - The eighth board will include both employee representatives and senior management directors, ensuring that neither group exceeds half of the total board members [1] - **Zhang Bin's Background** - Zhang Bin has held various positions since 2013, including roles in the Party and Mass Work Department and as a supervisor in multiple companies [2] - Currently, he serves as the vice chairman of the company's labor union and director of the Party Office [2]

Summary of Key Points Core Viewpoint - The company, Beijing Haitai Ruisheng Technology Co., Ltd., is providing a guarantee of up to 50 million yuan for its subsidiary, DATAOCEAN AI PTE. LTD., to support its overseas data business expansion and operational needs [1][2]. Group 1: Guarantee Details - The guarantee amount is set at a maximum of 50 million yuan, with no prior guarantee balance [1]. - The guarantee does not involve any counter-guarantee [1]. - The total external guarantee amount, including this guarantee, will not exceed 6.73% of the company's latest audited net assets [4]. Group 2: Company and Subsidiary Information - DATAOCEAN AI PTE. LTD. is a holding subsidiary established in Singapore in September 2024, with a registered capital of 50,000 USD [3]. - The company holds a 51% stake in DATAOCEAN AI PTE. LTD., while the major shareholder, PRIDE AI HOLDING LIMITED, holds 49% [3]. - The subsidiary reported total assets of 395.46 million yuan and a net profit of -11.78 million yuan for the first half of 2025 [3]. Group 3: Decision-Making Process - The board of directors approved the guarantee at a meeting held on September 5, 2025, and the matter will be submitted for shareholder approval due to the subsidiary's asset-liability ratio exceeding 70% [2][4]. - The board believes that providing this guarantee aligns with the company's global strategic layout and is within a controllable risk range [4].

Core Points - The announcement details the pledge extension of shares by the controlling shareholder, Shanghai Kangyi Investment Co., Ltd., which holds 47,291,400 shares, representing 30.43% of the total share capital of Green Kang Biochemical Co., Ltd. [1] - A total of 5,200,000 shares have been pledged for extension, accounting for 11.00% of the shares held by the controlling shareholder and 3.35% of the company's total share capital [1] - After the pledge extension, the cumulative pledged shares by the controlling shareholder and its concerted parties amount to 10,335,195 shares, which is 21.08% of their holdings and 6.65% of the company's total share capital [1][2] Share Pledge Details - As of the announcement date, the controlling shareholder has pledged a total of 10,335,195 shares, with no risk of forced liquidation or transfer, ensuring no substantial impact on the company's operations or governance [2] - The company will continue to monitor the changes in share pledges and fulfill its information disclosure obligations as required [2]

Core Viewpoint - The company plans to utilize part of its temporarily idle self-owned funds for cash management to enhance fund efficiency and increase returns while ensuring daily operations are not affected [1][4]. Summary by Sections Overview of Cash Management - The purpose of cash management is to improve the efficiency of idle funds and increase cash management returns while controlling risks [1]. - The funds for cash management will come from temporarily idle self-owned funds, which are legally compliant and will not affect normal operations [2]. Types of Investment Products - The company will invest in high-security, liquid financial products, including but not limited to structured deposits, agreement deposits, notice deposits, time deposits, and large certificates of deposit [2]. Amount and Duration - The company intends to use up to RMB 800 million (including principal) for cash management, with a validity period of 12 months from the board's approval [2][4]. - The funds can be used in a rolling manner within the approved amount and duration [2]. Implementation Method - The board authorizes the financial manager to make investment decisions and sign relevant contracts, with the finance department responsible for implementation [2]. Impact on the Company - The cash management initiative will not affect the company's main business operations and is expected to enhance fund efficiency and generate additional returns for the company and its shareholders [3][4]. Supervisory Board Opinion - The supervisory board agrees that using up to RMB 800 million for cash management will improve fund efficiency and increase returns without harming the company's or shareholders' interests [4].

Group 1 - The company held its 2025 semi-annual performance briefing on September 5, 2025, with key executives participating to address investor inquiries [1] - The company plans to focus on its core business and enhance energy supply capabilities, specifically advancing the construction of the Jiaxing Unit 10 and Taizhou Phase II [1] - For 2024, the company reported an expected revenue of 88 billion CNY and a net profit attributable to the parent company of 7.75 billion CNY, which is an increase of 3.2 billion CNY from the initial budget [1] Group 2 - The company indicated that the ratio of long-term, monthly, and spot electricity generation from thermal power in the first half of the year was approximately 80:20, with the tax-inclusive electricity price slightly below the benchmark price [1]

Investment Overview - The company plans to increase its investment in its wholly-owned subsidiary, LiaoCheng JinZhiQiao Import and Export Co., Ltd., to 30 million RMB to support its operational development and sustainable growth [1][2] - The investment will be funded through the company's own or raised funds [1] Progress of Investment - As of the date of the announcement, JinZhiQiao has completed the business registration change and received a new business license from the local market supervision administration [1] - The registered capital of JinZhiQiao is now 30 million RMB, and it operates as a limited liability company [1][2] - The business scope includes import and export of various goods and technologies, sales of machinery and equipment, chemical products, and consulting services, among others [1][2]